Recurrent portopulmonary hypertension after liver transplantation: Management with epoprostenol and resolution after retransplantation
β Scribed by Daniel H. Kett; Rita C. Acosta; Michael A. Campos; Miguel J. Rodriguez; Andrew A. Quartin; Roland M.H. Schein
- Book ID
- 111723043
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 57 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1527-6465
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Impact of hepatitis C virus (HCV) recurrence on long-term outcome after orthotopic liver transplantation (OLT) is highly variable, and the role of retransplantation is still debated. From 1996 to 2003, 131 OLT with histologically proven HCV recurrence and 6 months of follow-up were retrospectively r
outcomes need to be elucidated in future studies. Our patient developed liver fibrosis complicated by spur cell anemia 15 years after her initial OLT for biliary atresia. Liver retransplantation led to the resolution of her spur cell anemia and should be considered the treatment of choice in severe